DRIO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
DRIO is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has weak fundamental momentum, shrinking revenue, heavy losses, and no strong insider or proprietary buy signal to support an immediate purchase. Even though the price is near short-term resistance and the chart shows some positive momentum, the overall setup is not attractive for an impatient long-term buyer. My direct view: do not buy DRIO now.
The short-term trend is mixed to slightly positive, but not strong enough to justify a buy. MACD histogram is positive and expanding, which supports near-term momentum, yet RSI_6 at 74.84 suggests the stock is stretched. Moving averages are converging, indicating no strong trend confirmation. Price at 8.03 is just below resistance at 8.105 and below R2 at 8.385, with pivot support at 7.652 and deeper support at 7.2. Overall, the chart looks range-bound and near resistance rather than offering an attractive long-term entry.
Upcoming Q1 2026 earnings on 2026-05-13 could create a catalyst if results or guidance improve. MACD is positive and expanding, showing some near-term momentum. The stock is also trading close to short-term support/pivot levels, which may attract traders if momentum continues.
Revenue in 2025/Q4 fell 31.21% YoY to 5.231M, showing weak growth. Net loss remained very large at -37.53M, and gross margin also declined to 53.6%. Stifel cut its price target to $10 from $16 and said the stock is unlikely to regain momentum until revenue acceleration and profitability become clearer. Hedge funds are selling, with selling increasing 109.67% last quarter. Similar-pattern analysis points to negative forward returns over the next day, week, and month. No AI Stock Picker signal, no recent SwingMax signal, and no recent congress trading data were found.
Latest quarter provided: 2025/Q4. Revenue declined sharply by 31.21% YoY to 5.231M, which is a negative growth trend. Net income was still deeply negative at -37.53M, though the loss improved versus last year on a percentage basis. EPS remained deeply negative at -4.74. Gross margin fell to 53.6%, down 3.0% YoY. Overall, the latest quarter shows weak top-line growth and ongoing profitability issues.
Stifel lowered its price target to $10 from $16 on 2026-03-20 while keeping a Buy rating. However, the tone was cautious: the firm expects 2025 and 2026 revenue and EBITDA below consensus and said the stock likely will not regain momentum until there is better visibility on revenue acceleration and profitability. Wall Street’s view is therefore mixed: rating is technically positive, but the target cut and commentary are clearly a bearish caution on fundamentals.
